Adalimumab Dose Reduction and Withdrawal in Stable Non-Infectious Pediatric Uveitis: An Open-Label, Prospective, Pilot Study
Ocul Immunol Inflamm. 2024 Apr 23:1-8. doi: 10.1080/09273948.2024.2343084. Online ahead of print. ABSTRACT PURPOSES: This study investigated the feasibility of adalimumab (ADA) dose reduction and …